Sabby Capital actually dumped 68% of its Histogenics Corp (NASDAQ:HSGX) holdings, which is a medicine company, during the third quarter probably when the shares were trading above $3 per share. Mintz’s hedge fund had only 48K shares of the company at the end of September. Today, the fund disclosed a 800K share 5% stake in the company which is now trading at $1.75 per share. You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Sabby Healthcare Master Fund, Ltd | 0 | 553,783 | 0 | 553,783 | 553,783 | 3.48 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 43358V109 1. NAME OF REPORTING PERSONS Sabby Volatility Warrant Master Fund, Ltd. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 246,148 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 246,148 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 246,148 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.55 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 43358V109 1. NAME OF REPORTING PERSONS Sabby Management, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 799,931 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 799,931 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 799,931 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.02 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO CUSIP No. 43358V109 1. NAME OF REPORTING PERSONS Hal Mintz 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 799,931 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 799,931 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 799,931 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.02 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN CUSIP No. 43358V109 Item 1. (a). Name of Issuer Histogenics Corporation (b). Address of issuer s principal executive offices 830 Winter Street, 3rd Floor Waltham, Massachusetts 02451 Item 2. (a). Name of person filing Sabby Healthcare Master Fund, Ltd. Sabby Volatility Warrant Master Fund, Ltd. Sabby Management, LLC Hal Mintz (b). Address or principal business office or, if none, residence Sabby Healthcare Master Fund, Ltd. c o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. c o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458 Hal Mintz c o Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458 (c). Citizenship Sabby Healthcare Master Fund, Ltd. – Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. – Cayman Islands Sabby Management, LLC – Delaware, USA Hal Mintz – USA (d). Title of class of securities Common stock (e). CUSIP No. 43358V109 Item 3. If This Statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E) (f) An employee benefit plan or endowment fund in accordance with Section 240.13d- 1(b)(1)(ii)(F) (g) A parent holding company or control person in accordance with Section 240.13d- 1(b)(1)(ii)(G) (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813) (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J) (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned Sabby Healthcare Master Fund, Ltd. – 553,783 Sabby Volatility Warrant Master Fund, Ltd. – 246,148 Sabby Management, LLC – 799,931 Hal Mintz – 799,931 (b) Percent of class Sabby Healthcare Master Fund, Ltd. – 3.48% |
| Sabby Volatility Warrant Master Fund, Ltd | 0 | 246,148 | 0 | 246,148 | 246,148 | |
| Sabby Management | 0 | 799,931 | 0 | 799,931 | 799,931 | |
| Hal Mintz | 0 | 799,931 | 0 | 799,931 | 799,931 |
Follow Hal Mintz's Sabby Capital
Page 1 of 9 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
Histogenics Corporation
(Name of Issuer)
Common Shares
(Title of Class of Securities)
43358V109
(CUSIP Number)
December 13, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
__________
*The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a
prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934 (Act) or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
?
CUSIP No.
43358V109
